Model N Sponsors Leading Pharma and MedTech Conferences in November

Extends thought leadership at both CBI’s Gross-To-Net Accounting & Accruals and Q1’s Medical Device Contracting and Strategic Accounts Conference

REDWOOD CITY, CA – November 6th – Model N, Inc. (NYSE: MODN), the leading Revenue Management Cloud solutions provider to the life science and technology industries, announced today that it will be sponsoring two prominent life science events, CBI’s Gross-To-Net Accounting & Accruals November 19-20 in Philadelphia and Q1’s 2nd Annual Medical Device Contracting and Strategic Accounts Conference November 13-14 in Dallas.

At the Gross to Net Accounting & Accruals conference, Ajay Dawar, Model N Vice President of Product Management, will share the analytical best practices that life science companies should adopt to analyze their G2N and improve price transparency and maximize revenues.

“Understanding the true impact of rebates from a financial planning perspective is critical to drive an improvement in net revenues for life science companies,” said Dawar. “Through its sponsorship, Model N continues its thought leadership with these two important industry events.”

Model N Chief Industry Executive – MedTech, Ranjit Jose, will be speaking on “The Changing MedTech Market: Strategies to Survive and Thrive” at the 2nd Annual Medical Device Contracting and Strategic Accounts Conference.

“With developed markets trying to contain healthcare costs, the MedTech industry is going through a period of transformation,” Jose said. “Providers are consolidating and putting tremendous pressure on MedTech suppliers, resulting in new threats and opportunities.”

Resources:

• Model N for Life Science

• Model N Revenue Management

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process.  With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Contact

Brenda Christensen
Model N
Tel: 818.307.9942​​​​​
Email: bchristensen@modeln.com

Recent Posts

Start typing and press Enter to search